1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > 2015 Hematology and Flow Cytometry Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

2015 Hematology and Flow Cytometry Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • June 2015
  • -
  • Venture Planning Group
  • -
  • 306 pages

Summary

Table of Contents

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500.


Summary


This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years.  The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.


The report provides five-year volume and sales forecasts for over 40 hematology and flow cytometry procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers.


Strategic Recommendations


- New product development opportunities

with significant market appeal.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Hematology Tests


CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),

Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),

Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.


Flow Cytometry Tests


Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.


Sales and Market Share Analysis


- Sales and market shares of major

instrument and reagent suppliers.


Market Segmentation Analysis


- Sales and market share estimates for leading suppliers

of hematology and flow cytometry products.


- Test and sales forecasts for over 40 procedures

by individual test and market segment:


Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers


Current and Emerging Products


- Analysis of current and emerging hematology and flow cytometry tests.



- Reagent and instrument sales forecasts by market segment.



- Instrument placements and installed base by manufacturer and model.



- Sales and market shares of reagent and instrument suppliers.


Technology Review


- Assessment of current and emerging

technologies, and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Extensive strategic profiles of

major suppliers and emerging market entrants.


- The companies analyzed in the report include:


   - Abbott

   - Agilent Technologies

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Bio-Rad

   - CellaVision

   - Horiba

   - Iris

   - Nihon Kohden

   - Ortho-Clinical Diagnostics

   - Roche

   - Siemens

   - Sysmex


Contains 306 pages and 59 tables

This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years. The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

The report provides five-year volume and sales forecasts for over 40 hematology and flow cytometry procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21100
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the US

  • April 2017
    12 pages
  • Hospital  

  • United States  

View report >

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Hospital Industry

  • April 2017
    166 pages
  • Health Care Pro...  

    Hospital  

View report >

Healthcare Industry

10 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.